Chargement en cours...
Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis
Biological products for treatment of rheumatoid arthritis usually are cost effective for healthcare systems in Europe, but they are huge financial burden due to the high number of patients and the significant budget impact. The expected saving from introduction on the market of biosimilars are signi...
Enregistré dans:
| Publié dans: | Front Pharmacol |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6158404/ https://ncbi.nlm.nih.gov/pubmed/30294275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.01070 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|